Brief: BioXcel Therapeutics Q1 Basic EPS USD -1.5
12/05/2025 12:00
May 12 (Reuters) - BioXcel Therapeutics Q1 revenue USD 168 thousand. Q1 operating income USD -10.099 million Q1 net income USD -7.254 million Q1 operating expenses USD 10.267 million
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty